BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Cytokine Synergism in Apoptosis: Its Role in Diabetes and Cancer

  • Lee, Myung-Shik (Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine and National Research Laboratory of Cell Death and Diabetes Research)
  • Published : 2002.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

The effects of individual cytokine on apoptosis have been extensively studied. However, the effect of the cytokine combination, or the synergistic effect of cytokines on cell death, has not been widely studied, though synergism between cytokines has been documented in a variety of biological situations. In our effort to identify the final death effector molecule(s) in autoimmune diabetes, we inadvertently became interested in the cytokine synergism. We discovered that $IFN{\gamma}/TNF{\alpha}$ synergism, rather than the Fas ligand as currently believed, is responsible for the apoptosis of pancreatic islet cells both in vitro and in vivo. We also studied similar cytokine synergism in cancer cell deaths, and noted the similarities and dissimilarities between cancer cell death and islet cell death.

Keywords

References

  1. Amrani, A., Verdaguer, J., Anderson, B., Utsugi, T., Bou, S. andSantamaria, P. (1999) Perforin-independent $\beta$-cell destruction by diabetogenic CD8+ T lymphocytes in transgenic nonobesediabetic mice. J Clin. Invest. 103, 1201-1209. https://doi.org/10.1172/JCI6266
  2. Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, C. A. and Matis, L. A. (1997) The role of Fas in autoimmune diabetes. Cell 89, 17-24. https://doi.org/10.1016/S0092-8674(00)80178-6
  3. Chu, J. L., Ramos, P., Rosendorff, A., Nikolic-Zugic, J., Lacy, E.,Matsuzawa, A. and Elkon, K. B. (1995) Massive upregulationof the Fas ligand in Ipr and gld mice: Implications for Fasregulation and the graft-versus-host disease-like wastingsyndrome. J. Exp. Med. 181, 393-398. https://doi.org/10.1084/jem.181.1.393
  4. Enari, M., Talanian, R. V., Wong, W. W. and Nagata, S. (1996)Sequential activation of ICE-like and CPP32-like proteasesduring Fas-mediated apoptosis. Nature 380, 723-726. https://doi.org/10.1038/380723a0
  5. Fransen, L., Heyden, J., Ruysschaert, R. and Fiers, W. (1986)Recombinant tumor necrosis factor: its effect and its synergismwith interferon-$\gamma$ on a variety of normal and transformedhuman cell lines. Br. J. Cancer Clin. Oncol. 22,419-426. https://doi.org/10.1016/0277-5379(86)90107-0
  6. Haskins, K. and McDuffie, M. (1990) Acceleration of diabetes inyoung NOD mice with a CD4+ islet-specific T cell clone.Science 249, 1433-1436. https://doi.org/10.1126/science.2205920
  7. Hayashi, T. and Faustrnan, D. (1999) NOD mice are defective inproteasome production and activation of $NF-{\kappa}B$. Mol. Cell. BioI. 19, 8648-8659.
  8. Henkart, P. A. (1994) Lymphocyte-mediated cytotoxicity: twopathways and multiple effector molecules. Immunity 1, 343-346. https://doi.org/10.1016/1074-7613(94)90063-9
  9. Hisahara, M., Shoji, S., Okano, H. and Miura, M. (1997) ICE/CED-3 family executes oligodendrocyte apoptosis by tumornecrosis factor. J. Neurochem. 69, 10-20. https://doi.org/10.1046/j.1471-4159.1997.69010010.x
  10. Itoh, N., Imagawa, A., Hanafusa, T., Waguri, M., Yamamoto, K.,Iwasashi, H., Moriwaki, M., Nakajima, H., Miyagawa, M.,Namba, M., et al. (1997) Requirement of Fas for thedevelopment of autoimmune diabetes in nonobese diabeticmice. J. Exp. Med. 186,613-618. https://doi.org/10.1084/jem.186.4.613
  11. Ju, S.-T., Cui, H., Panka, D. J., Ettinger, R. and A., M.-R. (1994)Participation of target Fas protein in apoptosis pathway inducedby CD4+ Th1 and CD8+ cytotoxic T cells. Proc. Natl. Acad.Sci. USA 91, 4185-4189. https://doi.org/10.1073/pnas.91.10.4185
  12. Kagi, D., Odermatt, B., Ohashi, P. S., Zinkernagel, R. M. andHengartner, H. (1996) Development of insulitis withoutdiabetes in transgenic mice lacking perforin-dependentcytotoxicity. J Exp. Med. 183, 2143-2152. https://doi.org/10.1084/jem.183.5.2143
  13. Kagi, D., Odermatt, B., Seiler, P., Zinkemagel, R. M., Mak, T. W.and Hengartner, H. (1997) Reduced incidence and delayedonset of diabetes in perforin-deficient nonobese diabetic mice.J. Exp. Med. 186, 989-997. https://doi.org/10.1084/jem.186.7.989
  14. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V.,Nagata, S., Hengartner, H. and Golstein, P. (1994) Fas andperforin pathways as major mechanisms of T cell-mediatedcytotoxicity. Science 265, 528-530. https://doi.org/10.1126/science.7518614
  15. Kang, S. J., Wang, S., Hara, H., Peterson, E. P., Namura, S.,Arnin-Hanjani, S., Huang, Z., Srinivasan, A., Tomaselli, K. J.,Thornberry, N. A., Moskowitz, M. A. and Yuan, J. (2000) Dualrole of caspase-11 in mediating activation of caspase-1 andcaspase-3 under pathological condition. J. Cell BioI. 149, 613-622. https://doi.org/10.1083/jcb.149.3.613
  16. Kano, A., Haruyama, T., Akaike, T. and Watanabe, Y. (1999). IRF-1 is an essential mediator in IFN--${\gamma}$-induced cell cycle arrest and apoptosis in primary cultured hepatocytes. Biochem. Biophys. Res. Com. 257,672-677. https://doi.org/10.1006/bbrc.1999.0276
  17. Kim, S., Kim, J. Y., Lee, T. H., Suk, K., Cha, H.-S., Koh, E.-M., Yagita, H. and Lee, M.-S. Soluble Fas Ligand-Susceptible 'Memory' Cells in Mice but Not in Human: Potential role of soluble Fas ligand in deletion of autoreactive cells. Autoimmunity, in press.
  18. Kim, S., Kim, K.-A., Hwang, D.-Y., Lee, T. H., Kayagaki, N., Yagita, H. and Lee, M.-S. (2000) Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved. J. Immunol. 164, 2931-2936. https://doi.org/10.4049/jimmunol.164.6.2931
  19. Kim, Y-H., Kim, S., Kim, K.-A., Yagita, H., Kayagaki, N., Kim, K.-W. and Lee, M.-S. (1999) Apoptosis of pancreatic ${\beta}$-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur. J Immunol. 29, 455-465. https://doi.org/10.1002/(SICI)1521-4141(199902)29:02<455::AID-IMMU455>3.0.CO;2-A
  20. Kontny, H. U., Hammerle, K., Klein, R., Shayan, P., Mackall, C.L. and Niemeyer, C. M. (2001) Sensitivity of Ewing's sarcomato TRAIL-induced apoptosis. Cell Death Differ. 8, 505-514.
  21. Kumar, A., Commane, M., Flickinger, T. W., Horvath, C. M. andStark, G. R. (1997) Defective TNF-$\alpha$-induced apoptosis inSTAT1-null cells due to low constitutive levels of caspases.Science 278, 1630-1632. https://doi.org/10.1126/science.278.5343.1630
  22. Lee, M.-S., Kim, S., Chung, J. H., Lee, M.-K and Kim, K.-W.(1999) Fas is expressed in murine pancreatic islet cells and aninsulinoma cell line but does not mediate their apoptosis invitro. Autoimmunity 29, 189-199. https://doi.org/10.3109/08916939908998534
  23. Quirk, S. M., Porter, D. A., Huber, S. C. and Cowan, R. G.(1998) Potentiation of Fas-mediated apoptosis of murinegranulosa cells by interferon-gamma, tumor necrosis factoralpha,and cycloheximide. Endocrinology 139, 4860-4869. https://doi.org/10.1210/en.139.12.4860
  24. Reap, E. A., Roof, K., Maynor, K., Borrero, M., Booker, J. andCohen, P. L. (1997) Radiation and stress-induced apoptosis: Arole for FaslFas ligand interaction. Proc. Natl. Acad. Sci. USA94, 5750-5755. https://doi.org/10.1073/pnas.94.11.5750
  25. Suk, K., Kim, S., Kim, Y-H., Kim, K-A., Chang, I., Yagita, H.,Shong, M. and Lee, M.-S. (2001a) $IFN{\gamma}/TNF{\alpha}$ Synergism asthe Final Effector in Autoimmune Diabetes: A key role forIRF-1 in pancreatic $\beta$-cell death. J. lmmunol. 166,4481-4489. https://doi.org/10.4049/jimmunol.166.7.4481
  26. Suk, K., Kim, Y. H., Chang, I., Kim, J. Y., Choi, Y. H., Lee, K. Y.and Lee, M. S. (2001b) IFNalpha sensitizes ME-180 humancervical cancer cells to TNFalpha-induced apoptosis byinhibiting cytoprotective NF-kappaB activation. FEBS Letters495,66-70. https://doi.org/10.1016/S0014-5793(01)02335-3
  27. Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I.,Aizawa, S., Maatsuyama, T., Mak, T. W., Take, S. andTaniguchi, T. (1995) An IRF-l-dependent pathway of DNAdamage-induced apoptosis in mitogen-activated T lymphocytes.Nature 376, 596-599. https://doi.org/10.1038/376596a0
  28. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) Fas ligand in human serum. Nat. Med. 2, 317-322. https://doi.org/10.1038/nm0396-317
  29. Wang, S., Miura, M., Jung, Y.-K., Zhu, H. and Yuan, J. (1998)Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501-509. https://doi.org/10.1016/S0092-8674(00)80943-5
  30. Wang, Y., Pontesilli, O., Gill, R. D., La Rosa, F. G. and Lafferty,K. J. (1991) The role of CD4+ and CD8+ T cells in thedestruction of islet grafts by spontaneously diabetic mice. Proc.Natl. Acad. Sci. USA 88, 527-531. https://doi.org/10.1073/pnas.88.2.527
  31. Watanabe, D., Suda, T., Hashimoto, H. and Nagata, S. (1995)Constitutive activation of the Fas ligand gene in mouseIymphoproliferative disorders. EMBO J. 14, 12-18.
  32. Wicker, L. A., Miller, B. J. and Mullen, Y. (1986) Transfer ofautoimmune diabetes mellitus with splenocytes from nonobesediabetic (NOD) mice. Diabetes 35, 855-860. https://doi.org/10.2337/diabetes.35.8.855
  33. Wofsy, D., Hardy, R. R. and Seaman, W. (1984) The proliferatingcells in autoimmune MRL/1pr mice lack L3T4, an antigen on"helper" T cells that is involved in the response to class IImajor histocompatibility antigens. J. lmmunol. 132, 2686-2689.
  34. Yamada, K., Takane-Gyotoku, N., Yuan, X., Ichikawa, F. andNonaka, K. (1996) Mouse islet cell lysis mediated byinterleukin-1-induced Fas. Diabetologia 39, 1306-1312. https://doi.org/10.1007/s001250050574

Cited by

  1. Gene Therapy for Mice Sarcoma with Oncolytic Herpes Simplex Virus-1 Lacking the Apoptosis-inhibiting Gene, icp34.5 vol.36, pp.4, 2003, https://doi.org/10.5483/BMBRep.2003.36.4.379
  2. Effect of Sanguis draconis (a dragon's blood resin) on streptozotocin- and cytokine-induced β-cell damage, in vitro and in vivo vol.94, pp.3, 2011, https://doi.org/10.1016/j.diabres.2011.08.014
  3. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease vol.1843, pp.11, 2014, https://doi.org/10.1016/j.bbamcr.2014.05.014
  4. Endocrine sequelae of cancer and cancer treatments vol.1, pp.4, 2007, https://doi.org/10.1007/s11764-007-0038-6
  5. E1-L2 Activates Both Ubiquitin and FAT10 vol.27, pp.6, 2007, https://doi.org/10.1016/j.molcel.2007.08.020